La Fraise has secured a €3.2 million investment to enhance its AI-driven platform aimed at reducing treatment abandonment in dental care.
Target Information
La Fraise is an innovative startup founded in 2025 that specializes in enhancing dental practice management through the use of artificial intelligence. The company has developed AI agents designed to support dental teams by automating both repetitive and complex tasks. This revolutionary platform aims to alleviate common issues faced by dental professionals, such as managing treatment plans and navigating insurance communications, ultimately improving patient care.
Founded by four former Doctolib alumni — Cédric Turquem, Matthieu Kern, Victor Schubert, and Florian Duchêne — La Fraise benefits from the extensive experience of its team, which has over eight years of expertise in healthcare innovation. In conjunction with Arnaud Assous, a successful serial entrepreneur, they provide La Fraise with a solid foundation for growth and transformation in the dental care sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The dental care industry in France is witnessing significant challenges, with nearly one-third of individuals avoiding essential dental treatment primarily due to a lack of information regarding medical, f
Similar Deals
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
GO Capital and Critical Path Ventures → Alkion BioInnovations
2025
Kurma Partners, WE Life Sciences, French Tech Seed fund → Elkedonia
2025
20VC, Kima Ventures
invested in
La Fraise
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $3M